Roche’s Tecentriq triplet nabs melanoma OK, but BMS’ Opdivo-Yervoy still reigns supreme

Roche’s Tecentriq triplet nabs melanoma OK, but BMS’ Opdivo-Yervoy still reigns supreme
chelfand
Fri, 07/31/2020 – 01:54